November 14, 2022
November 03, 2022
Q3
$ -30.8M
-77.32 %
$ -17.4M
-292.73 %
$ -4.4M
CinCor Pharma, Inc.(CINC)
Sector:
HealthcareDescription:
CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial to treat chronic kidney diseases. The company was incorporated in 2018 and is based in Waltham, Massachusetts.Current Price
$29.06
RSI
32.46
Volume:
6,349,776